Neuberger Berman Group’s iRadimed IRMD Stock Holding History

Neuberger Berman Group’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$391K	Sell	4,095 -392	-9%	-$35.7K	﹤0.01%	1910
2026 Q1	$432K	Buy	4,487 +501	+13%	+$50.1K	﹤0.01%	1688
2025 Q4	$388K	Sell	3,986 -119	-3%	-$10.2K	﹤0.01%	1711
2025 Q3	$292K	Sell	4,105 -409	-9%	-$27.3K	﹤0.01%	1764
2025 Q2	$270K	Buy	4,514 +31	+0.7%	+$1.7K	﹤0.01%	1771
2025 Q1	$235K	Buy	4,483 +77	+2%	+$4.33K	﹤0.01%	1772
2024 Q4	$242K	Buy	+4,406	New	+$232K	﹤0.01%	1736
2018 Q4	–	Sell	-7,500	Closed	-$279K	–	1615
2018 Q3	$279K	Sell	7,500 -12,750	-63%	-$344K	﹤0.01%	1457
2018 Q2	$420K	Sell	20,250 -250	-1%	-$4.42K	﹤0.01%	1430
2018 Q1	$295K	Hold	20,500	–	–	﹤0.01%	1480
2017 Q4	$311K	Hold	20,500	–	–	﹤0.01%	1532
2017 Q3	$197K	Buy	20,500 +2,000	+11%	+$19K	﹤0.01%	1540
2017 Q2	$159K	Buy	18,500 +3,500	+23%	+$29.9K	﹤0.01%	1551
2017 Q1	$134K	Buy	+15,000	New	+$139K	﹤0.01%	1562

Other funds holding IRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Neuberger Berman Group's IRMD Position: Q2 2026 in Review

Neuberger Berman Group reduced its iRadimed (IRMD) stake by 8.7% in Q2 2026, selling an estimated $35.7K and leaving 4,095 shares worth $391K. The position accounts for ﹤0.01% of the portfolio, ranked #1910.

Neuberger Berman Group first reported a position in IRMD in Q1 2017 and has held it in 14 quarters since. The position peaked at $432K in Q1 2026. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

Neuberger Berman Group held 4,095 shares of iRadimed worth $391K as of Q2 2026.
Neuberger Berman Group sold 392 iRadimed shares in Q2 2026, an estimated $35.7K.
iRadimed made up ﹤0.01% of Neuberger Berman Group's portfolio in Q2 2026, its #1910 holding.
Neuberger Berman Group first reported a position in iRadimed in Q1 2017 and has held it in 14 quarters since.
Neuberger Berman Group's iRadimed position peaked at $432K in Q1 2026.
214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Neuberger Berman Group's 13F filing for Q2 2026, filed 13 Aug 2026.